Location History:
- Boulder, CO (US) (2010)
- Jersey City, NJ (US) (2006 - 2011)
Company Filing History:
Years Active: 2006-2011
Title: Michel J Hamelin: Innovator in Nucleic Acid Technologies
Introduction
Michel J Hamelin is a notable inventor based in Jersey City, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid molecules and their applications.
Latest Patents
Michel J Hamelin holds 5 patents that focus on isolated nucleic acid molecules, specifically polynucleotides that encode glutamate gated chloride channels. His latest inventions also include recombinant vectors and hosts that contain DNA fragments encoding these channels. These innovations are aimed at producing substantially purified forms of glutamate gated chloride channels and recombinant membrane fractions that comprise these proteins. Additionally, his work involves methods for identifying compounds that modulate these channels, which have potential applications as insecticides.
Career Highlights
Throughout his career, Michel has worked with prominent companies such as Merial Limited and Merck & Co., Inc. His experience in these organizations has allowed him to advance his research and contribute to significant developments in the field.
Collaborations
Michel has collaborated with esteemed colleagues, including Jeffrey W Warmke and Youfeng Yang. These partnerships have further enriched his research endeavors and innovations.
Conclusion
Michel J Hamelin is a distinguished inventor whose work in nucleic acid technologies has the potential to impact various industries, particularly in pest control. His contributions continue to shape the future of biotechnology.